Key result
Machine learning models, such as support vector machines, were superior to the ELECTRa Registry Outcome Score for predicting major adverse events after transvenous lead extraction.
Why the study?
Transvenous lead extraction remains a high-risk procedure, motivating the development of a machine learning-based risk stratification system to predict procedure-related major adverse events.
Do machine learning models improve the prediction of major adverse events compared to the EROS score in patients undergoing transvenous lead extraction?
Observational (n=4,726)
Yes
Do machine learning models improve the prediction of major adverse events compared to the EROS score in patients undergoing transvenous lead extraction?
Machine learning models provide superior and personalized risk prediction for major adverse events during transvenous lead extraction compared to traditional scoring systems.
Answers are grounded in this paper and cite their sources.
Supports lead extraction safety in large registry; ML risk models remain hypothesis-generating pending validation.
BACKGROUND: Transvenous lead extraction (TLE) remains a high-risk procedure. OBJECTIVE: The purpose of this study was to develop a machine learning (ML)-based risk stratification system to predict the risk of major adverse events (MAEs) after TLE. A MAE was defined as procedure-related major complication and procedure-related death. METHODS: We designed and evaluated an ML-based risk stratification system trained using the European Lead Extraction ConTRolled (ELECTRa) registry to predict the risk of MAEs in 3555 patients undergoing TLE and tested this on an independent registry of 1171 patients. ML models were developed, including a self-normalizing neural network (SNN), stepwise logistic regression model ("stepwise model"), support vector machines, and random forest model. These were compared with the ELECTRa Registry Outcome Score (EROS) for MAEs. RESULTS: There were 53 MAEs (1.7%) in the training cohort and 24 (2.4%) in the test cohort. Thirty-two clinically important features were used to train the models. ML techniques were similar to EROS by balanced accuracy (stepwise model: 0.74 vs EROS: 0.70) and superior by area under the curve (support vector machines: 0.764 vs EROS: 0.677). The SNN provided a finite risk for MAE and accurately identified MAE in 14 of 169 "high (>80%) risk" patients (8.3%) and no MAEs in all 198 "low (<20%) risk" patients (100%). CONCLUSION: ML models incrementally improved risk prediction for identifying those at risk of MAEs. The SNN has the additional advantage of providing a personalized finite risk assessment for patients. This may aid patient decision making and allow better preoperative risk assessment and resource allocation.
No takes yet. Share an insight, caveat, or question.
Mehta et al. (2022) conducted an observational in Transvenous lead extraction (n=4,726). Machine learning-based risk stratification models vs. ELECTRa Registry Outcome Score (EROS) was evaluated on Major adverse events (procedure-related major complication and procedure-related death). Machine learning models, such as support vector machines, were superior to the ELECTRa Registry Outcome Score for predicting major adverse events after transvenous lead extraction.
Synapse has enriched 10 related papers. Consider them for comparative context: